These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17979597)

  • 1. Monoclonal antibodies for prophylaxis and therapy of infectious diseases.
    ter Meulen J
    Expert Opin Emerg Drugs; 2007 Nov; 12(4):525-40. PubMed ID: 17979597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibodies for treating infectious diseases].
    Klinguer-Hamour C; Caussanel V; Beck A
    Med Sci (Paris); 2009 Dec; 25(12):1116-20. PubMed ID: 20035689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention, detection, and management of early bacterial and fungal infections in a preclinical cardiac xenotransplantation model that achieves prolonged survival.
    Teotia SS; Walker RC; Schirmer JM; Tazelaar HD; Michaels MG; Risdahl JM; Byrne GW; Logan JS; McGregor CG
    Xenotransplantation; 2005 Mar; 12(2):127-33. PubMed ID: 15693843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern recognition receptors as therapeutic targets for bacterial, viral and fungal sepsis.
    Yuki K; Koutsogiannaki S
    Int Immunopharmacol; 2021 Sep; 98():107909. PubMed ID: 34182242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth and potential of human antiviral monoclonal antibody therapeutics.
    Marasco WA; Sui J
    Nat Biotechnol; 2007 Dec; 25(12):1421-34. PubMed ID: 18066039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody Therapy for the Control of Viral Diseases: An Update.
    Dibo M; Battocchio EC; Dos Santos Souza LM; da Silva MDV; Banin-Hirata BK; Sapla MMM; Marinello P; Rocha SPD; Faccin-Galhardi LC
    Curr Pharm Biotechnol; 2019; 20(13):1108-1121. PubMed ID: 31400263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines.
    De Serrano LO; Burkhart DJ
    J Nanobiotechnology; 2017 Nov; 15(1):83. PubMed ID: 29149896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infections in liver transplant recipients.
    Arslan H
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():24-7. PubMed ID: 24635787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents.
    Baldridge JR; McGowan P; Evans JT; Cluff C; Mossman S; Johnson D; Persing D
    Expert Opin Biol Ther; 2004 Jul; 4(7):1129-38. PubMed ID: 15268679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplant infectious disease: a work in progress.
    Rubin RH
    Transpl Infect Dis; 2005 Jun; 7(2):49-50. PubMed ID: 16150089
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial stewardship: a collaborative partnership between infection preventionists and health care epidemiologists.
    Moody J; Cosgrove SE; Olmsted R; Septimus E; Aureden K; Oriola S; Patel GW; Trivedi KK
    Am J Infect Control; 2012 Mar; 40(2):94-5. PubMed ID: 22381221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of doxycycline in vector-borne diseases.
    Olivera MP; Faccini-Martínez ÁA; Pérez-Díaz CE; Rodriguez-Morales AJ
    Int J Antimicrob Agents; 2015 Oct; 46(4):478-9. PubMed ID: 26206593
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of antimicrobial agents and chemotherapy from 1972 to 1998.
    Swartz MN
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2009-16. PubMed ID: 10898668
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against viruses and bacteria: a survey of patents.
    Xiao X; Dimitrov DS
    Recent Pat Antiinfect Drug Discov; 2007 Nov; 2(3):171-7. PubMed ID: 18221173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-Gamma: Treatment Horizons.
    Khryanin AA; Reshetinikov OV
    Antibiot Khimioter; 2016 Aug; 61():35-40. PubMed ID: 29874451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious complications following T-cell depleted hematopoietic stem-cell transplantation.
    Novitzky N; Rouskova A
    Cytotherapy; 2001; 3(3):165-73. PubMed ID: 12171723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune response to antibiotics in patients with secondary immunodeficiencies].
    Meroni PL
    J Chemother; 1994 Aug; 6 Suppl 3():16-8. PubMed ID: 7861203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody-based therapies for bacterial infections.
    Motley MP; Banerjee K; Fries BC
    Curr Opin Infect Dis; 2019 Jun; 32(3):210-216. PubMed ID: 30950853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recombinant monoclonal antibodies for the treatment and prevention of viral infections].
    Al'khovskiĭ SV
    Vestn Ross Akad Med Nauk; 2011; (5):49-53. PubMed ID: 21786598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.